CytomX Therapeutics, Inc.
CTMX
$3.36
$0.010.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.74% | 152.97% | -4.58% | -9.15% | 97.89% |
| Total Receivables | 5,936.22% | -67.91% | 23.57% | -12.84% | -4.45% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -48.39% | 18.27% | 22.56% | -15.07% | -2.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.68% | 145.34% | -3.55% | -9.36% | 90.03% |
|
|
|||||
| Total Current Assets | 5.68% | 145.34% | -3.55% | -9.36% | 90.03% |
| Net Property, Plant & Equipment | 82.35% | -28.64% | -28.08% | -17.21% | -14.98% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -8.98% | -8.45% | -7.59% | -7.06% | -6.76% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -58.86% | 0.00% | 44.39% | -0.46% | -0.46% |
| Total Assets | 6.09% | 137.10% | -4.23% | -9.60% | 77.73% |
|
|
|||||
| Total Accounts Payable | 41.74% | 5.15% | 101.39% | 184.58% | -17.75% |
| Total Accrued Expenses | 3.61% | -15.88% | 15.03% | 8.65% | 7.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -47.62% | -32.64% | -24.23% | 2.81% | 2.83% |
| Total Finance Division Other Current Liabilities | 34.67% | -33.55% | 19.74% | 1.14% | -34.83% |
| Total Other Current Liabilities | 34.67% | -33.55% | 19.74% | 1.14% | -34.83% |
| Total Current Liabilities | 17.16% | -27.01% | 13.61% | 4.60% | -21.87% |
|
|
|||||
| Total Current Liabilities | 17.16% | -27.01% | 13.61% | 4.60% | -21.87% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -49.51% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 550.88% | -9.29% | -39.58% | -32.08% | -28.98% |
| Total Liabilities | 100.84% | -25.01% | 3.33% | -7.76% | -24.92% |
|
|
|||||
| Common Stock & APIC | 0.29% | 29.50% | 2.67% | 0.21% | 13.70% |
| Retained Earnings | -2.83% | -2.56% | -4.32% | -2.13% | -0.02% |
| Treasury Stock & Other | -292.16% | -8.11% | 6.73% | 215.15% | 3,400.00% |
| Total Common Equity | -5.59% | 223.15% | -7.80% | -10.44% | 378.70% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.59% | 223.15% | -7.80% | -10.44% | 378.70% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.59% | 223.15% | -7.80% | -10.44% | 378.70% |
|
|
|||||